Landi Renzo SpA
MIL:LR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Landi Renzo SpA
MIL:LR
|
IT |
|
Saratoga Investama Sedaya Tbk PT
IDX:SRTG
|
ID |
|
Ultimovacs ASA
F:7UM
|
NO |
|
C
|
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
|
CN |
|
IG Design Group PLC
LSE:IGR
|
UK |
|
K
|
Kingkey Financial International Holdings Ltd
HKEX:1468
|
HK |
|
Wagners Holding Company Ltd
ASX:WGN
|
AU |
Income Statement
Earnings Waterfall
Landi Renzo SpA
Income Statement
Landi Renzo SpA
| Dec-2020 | Dec-2021 | Dec-2022 | ||
|---|---|---|---|---|
| Revenue | ||||
| Revenue |
143
N/A
|
245
+71%
|
308
+26%
|
|
| Gross Profit | ||||
| Cost of Revenue |
(84)
|
(150)
|
(189)
|
|
| Gross Profit |
59
N/A
|
94
+61%
|
119
+26%
|
|
| Operating Income | ||||
| Operating Expenses |
(63)
|
(96)
|
(122)
|
|
| Selling, General & Administrative |
(51)
|
(80)
|
(105)
|
|
| Depreciation & Amortization |
(12)
|
(16)
|
(17)
|
|
| Operating Income |
(4)
N/A
|
(1)
+67%
|
(4)
-172%
|
|
| Pre-Tax Income | ||||
| Interest Income Expense |
(5)
|
6
|
(6)
|
|
| Non-Reccuring Items |
(1)
|
(2)
|
(2)
|
|
| Total Other Income |
(0)
|
(1)
|
(1)
|
|
| Pre-Tax Income |
(11)
N/A
|
2
N/A
|
(14)
N/A
|
|
| Net Income | ||||
| Tax Provision |
4
|
(1)
|
(0)
|
|
| Income from Continuing Operations |
(8)
|
1
|
(14)
|
|
| Income to Minority Interest |
0
|
(2)
|
(0)
|
|
| Net Income (Common) |
(8)
N/A
|
(1)
+87%
|
(14)
-1 362%
|
|
| EPS (Diluted) |
-0.06
N/A
|
-0.01
+83%
|
-0.06
-500%
|
|